Lotus Eye Hospital and Institute Ltd
LOTUSEYE
Price Chart
Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
AvgFinancials growth has been moderate for a few years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 32.86 | 2.39 | 0.80% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 32.79 | 3.97 | 0.98% |
Forecast & RatingsDetailed Forecast
Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Lotus Eye Hospital and Institute Limited is engaged in the provision of healthcare services. The Company is engaged in the field of ophthalmology (eye) and its related operation.
PeersCompare with peers
Apollo Hospitals Enterprise Ltd
Max Healthcare Institute Ltd
Fortis Healthcare Ltd
Narayana Hrudayalaya Ltd
Dr. Lal PathLabs Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Holdings TrendDetailed holdings
Low Pledged Promoter HoldingLower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
Mutual Fund HoldingIncreasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock
In last 3 months, mutual fund holding of the company has almost stayed constant
Recent NewsAll news
Hmm, looks like data is unavailable here. Please come back after some timeRecent EventsAll events
Updates
Lotus Eye Hospital and Institute Limited has informed the Exchange regarding 'Results of Voting by Postal Ballot and Scrutinizer s Report'. | Download
Lotus Eye Hospital and Institute Limited has informed the Exchange regarding 'Results of Voting by Postal Ballot and Scrutinizer s Report'. | Download
Reply to Clarification- Financial results
The Exchange had sought clarification from Lotus Eye Hospital and Institute Limited for the quarter ended 31-Dec-2022 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Segment details not submitted The response of the Company is enclosed. | Download
The Exchange had sought clarification from Lotus Eye Hospital and Institute Limited for the quarter ended 31-Dec-2022 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Segment details not submitted The response of the Company is enclosed. | Download
Cash Dividend
Final • Div/Share: ₹ 0.5
Total Promoter HoldingIncreasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant